In this episode, Brian E. Lacy, MD, PhD, joins us to discuss the American College of Gastroenterology’s newest guidelines for irritable bowel syndrome, options for patients with IBS-D and IBS-C, and much more.
Trending
- Lessons from Sam Holliday, CEO and Co-Founder of Oshi Health, on Building a Virtual GI Center of Excellence (Pear Healthcare Playbook)
- UnitedHealth Adopts Aggressive Approach to Recover Ransomware Attack Loans (The HIPAA Journal)
- Cardinal Health’s acquisition of GI Alliance: What is means for the industry (Becker’s GI & Endoscopy)
- Why SIBO is often misdiagnosed as IBS [PODCAST] (KevinMD)
- Pfizer to discontinue its GLP-1 pill for obesity due to liver toxicity (STAT)
- The AI Paradigm: A Doctor’s Perspective (The Second Opinion)
- Lilly’s oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial (PRNewswire)
- Gas-sensing capsule takes another big step from lab to commercialization (EurekAlert!)
